BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND PSA AND Diagnosis
38 results:

  • 1. testicular metastasis of prostate adenocarcinoma: the other side of orchiepididymitis.
    Di Rienzo G; Tafuni A; Maestroni U; Ruffini L; Silini EM; Gasparro D; Pilato FP; Gnetti L
    Pathologica; 2024 Feb; 116(1):69-74. PubMed ID: 38482677
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Bilateral Adrenal and testicular Tumours; When a Simple diagnosis Becomes Complicated.
    Grootemaat M; Tjiam I; Sampimon D; Bot F; Roshani H
    Urology; 2023 May; 175():e11-e12. PubMed ID: 36828262
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prostate cancer testicular metastasis: Are they underestimated? Case report and analysis of the literature.
    Smelzo S; Mantica G; Lucianò R; Tenace NP; De Marchi D; Pini G; Passaretti G; Losa A; Gaboardi F
    Urologia; 2022 Nov; 89(4):645-647. PubMed ID: 33832367
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Testosterone deficiency syndrome: diagnosis and treatment.
    García-Cruz E; Alcaraz A
    Actas Urol Esp (Engl Ed); 2020 Jun; 44(5):294-300. PubMed ID: 32423612
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Solitary prostatic cancer metastasis to the testis: A case report and lessons to learn.
    Ismail A; Elmansy H; Shahrour W; Prowse O; Kotb A
    Arch Ital Urol Androl; 2020 Jan; 91(4):265-266. PubMed ID: 31937094
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand.
    Karunasinghe N; Symes E; Gamage A; Wang A; Murray P; Zhu S; Goudie M; Masters J; Ferguson LR
    PLoS One; 2019; 14(5):e0217373. PubMed ID: 31125365
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Adenocarcinoma of the Rete Testis: Clinicopathologic and Immunohistochemical Characterization of 6 Cases and Review of the Literature.
    Al-Obaidy KI; Idrees MT; Grignon DJ; Ulbright TM
    Am J Surg Pathol; 2019 May; 43(5):670-681. PubMed ID: 30676333
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Influence of Aldo-keto Reductase 1C3 in Prostate cancer - A Mini Review.
    Karunasinghe N; Masters J; Flanagan JU; Ferguson LR
    Curr Cancer Drug Targets; 2017; 17(7):603-616. PubMed ID: 28359237
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Metastasis of Prostate Adenocarcinoma to the Testis.
    Campara Z; Simic D; Aleksic P; Spasic A; Milicevic S
    Med Arch; 2016 Jul; 70(4):318-320. PubMed ID: 27703299
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Unilateral testicular metastasis of low psa level prostatic adenocarcinoma.
    Shinn BJ; Greenwald DW; Ahmad N
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25994435
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Pharmacological therapy of urogenital cancer: rational routine diagnostic imaging].
    Heidenreich A; Krege S
    Urologe A; 2013 Nov; 52(11):1564-73. PubMed ID: 24197084
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Follicle-stimulating hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis of prostate cancer and subsequent cluster selection of the patient population undergoing standard radical prostatectomy.
    Porcaro AB; Migliorini F; Petrozziello A; Sava T; Romano M; Caruso B; Cocco C; Ghimenton C; Zecchinini Antoniolli S; Lacola V; Rubilotta E; Monaco C; Comunale L
    Urol Int; 2013; 90(1):45-55. PubMed ID: 23128438
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Investigative clinical study on prostate cancer part IX and X: estradiol and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy.
    Porcaro AB; Ghimenton C; Petrozziello A; Sava T; Migliorini F; Romano M; Caruso B; Cocco C; Antoniolli SZ; Lacola V; Rubilotta E; Monaco C
    Anticancer Res; 2012 Oct; 32(10):4523-32. PubMed ID: 23060581
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. An unusual variant of prostatic adenocarcinoma with metastasis to testis. A case report.
    Anila KR; Somanathan T; Mathews A; Jayasree K
    Gulf J Oncolog; 2012 Jul; (12):73-6. PubMed ID: 22773221
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Investigative clinical study on prostate cancer part VIII: prolactin hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy.
    Porcaro AB; Ghimenton C; Petrozziello A; Migliorini F; Romano M; Sava T; Caruso B; Cocco C; Antoniolli SZ; Lacola V; Rubilotta E; Monaco C; Comunale L
    Anticancer Res; 2012 Apr; 32(4):1499-506. PubMed ID: 22493393
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Investigative clinical study on prostate cancer part VI: Follicle-stimulating hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population.
    Porcaro AB; Migliorini F; Petrozziello A; Sava T; Romano M; Caruso B; Cocco C; Ghimenton C; Zecchinini Antoniolli S; Lacola V; Rubilotta E; Monaco C; Comunale L
    Urol Int; 2012; 88(2):150-7. PubMed ID: 22205171
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Investigative clinical study on prostate cancer Part V: Luteinizing hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population.
    Porcaro AB; Petrozziello A; Migliorini F; Caruso B; Cocco C; Sava T; Ghimenton C; Romano M; Monaco C; Comunale L
    Anticancer Res; 2011 Mar; 31(3):1071-8. PubMed ID: 21498741
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A single episode of haematospermia can be safely managed in the community.
    Wilson C; Boyd K; Mohammed A; Little B
    Int J Clin Pract; 2010 Sep; 64(10):1436-9. PubMed ID: 20716149
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006.
    Bray F; Klint A; Gislum M; Hakulinen T; Engholm G; Tryggvadóttir L; Storm HH
    Acta Oncol; 2010 Jun; 49(5):644-54. PubMed ID: 20151937
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
    Sturgeon CM; Duffy MJ; Stenman UH; Lilja H; Brünner N; Chan DW; Babaian R; Bast RC; Dowell B; Esteva FJ; Haglund C; Harbeck N; Hayes DF; Holten-Andersen M; Klee GG; Lamerz R; Looijenga LH; Molina R; Nielsen HJ; Rittenhouse H; Semjonow A; Shih IeM; Sibley P; Sölétormos G; Stephan C; Sokoll L; Hoffman BR; Diamandis EP;
    Clin Chem; 2008 Dec; 54(12):e11-79. PubMed ID: 19042984
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.